Error loading player: No playable sources found
114076
WATCH NOW: Utilizing HiBiT Targeted Cell Killing Bioassays To Validate Cell Therapy and mAb-Mediated Immunotherapy Potency
Date
June 11, 2024
This product is not available for individual purchase, but it is available as part of the following products:
This technical Seminar will be available to watch on demand 24/7 during the Symposium. Click on this session to access the presentation video.
NOTE: If prompted to login to view the video, enter your CASSS member credentials.
Presented by: Promega Corporation
Speaker
Related Products
Plenary Session 4 - Potency Assays for Gene Edited Products
Measurement of the biological activity is crucial for lot release, stability and any comparability exercise of all biological medicinal products…
WATCH NOW: Limiting Off-Target Effects of CRISPR-Based Products- Guide RNA Sequencing by NGS
This technical Seminar will be available to watch on demand 24/7 during the Symposium. Click on this session to access the presentation video…
Plenary Session 1 - Genetic Modification Technologies for Cell-based Gene Therapies
In addition to the now well-known CAR T (chimeric antigen receptor T cells) and HSC (CD34+ hematopoietic stem cells) cell-based gene therapies, there are several other modes of gene modification as well as cell types already approved and on the horizon…
Comparability Regulatory Panel & Closing Remarks
Engaging Global Regulators in Discussion on Comparability for Cell-based Medicinal Products: Industry Challenges and a Path Towards Harmonized Solutions
